Connection

C Pradier to Treatment Outcome

Back to Details
This is a "connection" page, showing publications C Pradier has written about Treatment Outcome.
C Pradier
Connection Strength
0.076
Treatment Outcome
  1. Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes. J Thromb Haemost. 2018 03; 16(3):500-507.
    View in: PubMed
    Score: 0.027
  2. Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica. Reumatismo. 2018 Mar 27; 70(1):18-22.
    View in: PubMed
    Score: 0.014
  3. Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS? Rev Neurol (Paris). 2017 Apr; 173(4):222-224.
    View in: PubMed
    Score: 0.013
  4. Tools in the assessment of sarcopenia. Calcif Tissue Int. 2013 Sep; 93(3):201-10.
    View in: PubMed
    Score: 0.010
  5. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization. Curr Vasc Pharmacol. 2018; 16(4):405-413.
    View in: PubMed
    Score: 0.007
  6. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bone Marrow Transplant. 2017 May; 52(5):678-682.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.